Cargando…
Prenatal Substance Exposure and Neonatal Abstinence Syndrome: State Estimates from the 2016–2020 Transformed Medicaid Statistical Information System
INTRODUCTION: Estimating Neonatal Abstinence Syndrome (NAS) and prenatal substance exposure rates in Medicaid can help target program efforts to improve access to services. METHODS: The data for this study was extracted from the 2016–2020 Transformed Medicaid Statistical Information System (T-MSIS)...
Autores principales: | West, Kristina D., Ali, Mir M., Blanco, Martin, Natzke, Brenda, Nguyen, Linda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204012/ https://www.ncbi.nlm.nih.gov/pubmed/37219692 http://dx.doi.org/10.1007/s10995-023-03670-z |
Ejemplares similares
-
Postpartum Treatment for Substance Use Disorder Among Mothers of Infants with Neonatal Abstinence Syndrome and Prenatal Substance Exposure
por: Faherty, Laura J., et al.
Publicado: (2021) -
Estimating the impact of neonatal abstinence system interventions on Medicaid: an incremental cost analysis
por: López-Soto, Diana, et al.
Publicado: (2021) -
Neonatal Abstinence Syndrome in Infants with Prenatal Exposure to Methadone versus Buprenorphine
por: Kushnir, Alla, et al.
Publicado: (2023) -
Neonatal Abstinence Syndrome: An Insight Over Impact of Maternal Substance Use
por: Dumbhare, Omkar, et al.
Publicado: (2023) -
Neonatal Adaptation in Infants Prenatally Exposed to Antidepressants- Clinical Monitoring Using Neonatal Abstinence Score
por: Forsberg, Lisa, et al.
Publicado: (2014)